| Literature DB >> 31888109 |
Zhelun Zhang1,2, Luyao Tang1,2, Mengmeng Bao1,2, Zhigang Liu1,2, Wengong Yu1,2, Feng Han1,2.
Abstract
Alginate lyases degrade alginate into oligosaccharides, of which the biological activities have vital roles in various fields. Some alginate lyases contain one or more carbohydrate-binding modules (CBMs), which assist the function of the catalytic modules. However, the precise function of CBMs in alginate lyases has yet to be fully elucidated. We have identified a new multi-domain alginate lyase, TsAly7B, in the marine bacterium Thalassomonas sp. LD5. This novel lyase contains an N-terminal CBM9, an internal CBM32, and a C-terminal polysaccharide lyase family 7 (PL7) catalytic module. To investigate the specific function of each of these CBMs, we expressed and characterized the full-length TsAly7B and three truncated mutants: TM1 (CBM32-PL7), TM2 (CBM9-PL7), and TM3 (PL7 catalytic module). CBM9 and CBM32 could enhance the degradation of alginate. Notably, the specific activity of TM2 was 7.6-fold higher than that of TM3. CBM32 enhanced the resistance of the catalytic module to high temperatures. In addition, a combination of CBM9 and CBM32 showed enhanced thermostability when incubated at 80 °C for 1 h. This is the first report that finds CBM9 can significantly improve the ability of enzyme degradation. Our findings provide new insight into the interrelationships of tandem CBMs and alginate lyases and other polysaccharide-degrading enzymes, which may inspire CBM fusion strategies.Entities:
Keywords: alginate lyase; brown algae; carbohydrate-binding module; enzymatic activity; enzymatic characterization; polysaccharide lyase; product distribution; thermostability
Mesh:
Substances:
Year: 2019 PMID: 31888109 PMCID: PMC7024181 DOI: 10.3390/md18010025
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Construction of FL TsAly7B and three truncated mutants. (A) Domain structure of FL TsAly7B and three truncated mutants. (B) SDS_PAGE showing the FL, TM1, TM2, and TM3 proteins. Lane M, marker. Lane 1, TsAly7B-FL. Lane 2, TM1. Lane 3, TM2. Lane 4, TM3.
Figure 2Effects of temperature and pH on the FL TsAly7B and three truncated mutants. Optimal temperature (A), optimal pH (B), thermal stability (C), and pH stability (D) of the FL TsAly7B and three truncated mutants. For optimal temperature (A) and optimal pH (B), the highest activity of each enzyme (11.7 U/mL) was set as 100%; for thermal stability (C), and pH stability (D), the original activity (15.1 U/mL) was set as 100%. Values represent the mean of three replicates ± standard deviation.
Figure 3Effects of NaCl concentration on the activity of the FL TsAly7B and three truncated mutants. The relative activity of 100% was determined at the optimal pH, temperature, and NaCl concentration.
Effects of reagents on activities of TsAly7B and truncated mutants.
| Reagents | Concentration | Relative Activity (%) | |||
|---|---|---|---|---|---|
| TsAly7B-FL | TsAly7B-TM1 | TsAly7B-TM2 | TsAly7B-TM3 | ||
| None | - | 100 | 100 | 100 | 100 |
| NH4Cl | 1 | 108.13 ± 3.56 | 102.04 ± 4.39 | 104.4 ± 12.19 | 102.31 ± 2.41 |
| LiCl | 1 | 105.58 ± 9.71 | 99.78 ± 4.37 | 77.14 ± 9.68 | 95.81 ± 9.31 |
| KCl | 1 | 104.28 ± 5.86 | 96.6 ± 3.53 | 107.47 ± 5.3 | 103.05 ± 2.94 |
| MgCl2 | 1 | 100.39 ± 2.37 | 100.7 ± 7.84 | 83.19 ± 3.92 | 100.57 ± 5.58 |
| CaCl2 | 1 | 114.36 ± 6.95 | 89.91 ± 12.71 | 100.82 ± 4.81 | 105.11 ± 10 |
| MnCl2 | 1 | 89.31 ± 7.92 | 93.31 ± 24.01 | 84.89 ± 3.58 | 50.47 ± 3.85 |
| BaCl2 | 1 | 91.29 ± 16.32 | 86.71 ± 10.09 | 50.34 ± 3.6 | 83.76 ± 7.6 |
| EDTA | 1 | 3.29 ± 0.58 | 1.1 ± 0.77 | 4.61 ± 3.59 | 2.26 ± 1.72 |
| SDS | 1 | 100.9 ± 3.19 | 89.86 ± 3.14 | 79.15 ± 3.94 | 90.24 ± 7.2 |
The relative activity of 100% was determined at optimal pH and temperature in the presence of 0.5 M NaCl.
The specific activity of TsAly7B and truncated mutants.
| Protein | Specific Activity | Molecular Weight | Specific Activity |
|---|---|---|---|
| TsAly7B-FL | 488.8 ± 12.4 | 64.79 | 31.6 ± 0.8 |
| TsAly7B-TM1 | 869.1 ± 9.1 | 51.35 | 44.6 ± 0.5 |
| TsAly7B-TM2 | 1147.2 ± 19.7 | 52.66 | 60.4 ± 1.0 |
| TsAly7B-TM3 | 238.4 ± 5.6 | 33.78 | 8.0 ± 0.2 |
Values were determined at the optimal pH and temperature in the presence of 0.5 M NaCl.
The substrate specificity of TsAly7B and truncated mutants.
| Relative Activity (%) | ||||
|---|---|---|---|---|
| Substrate | FL | TM1 | TM2 | TM3 |
| Alginate | 100 | 100 | 100 | 100 |
| PolyM | 110.93 ± 3.23 | 96.61 ± 12.46 | 97.08 ± 2.43 | 107.38 ± 28.33 |
| PolyG | 91.29 ± 4.6 | 81.47 ± 18.13 | 103.21 ± 5.81 | 43.05 ± 11.62 |
The relative activity of 100% was determined at optimal pH and temperature in the presence of 0.5 M NaCl.
Figure 4FPLC analysis of end products of the FL TsAly7B and three truncated mutants. Unsaturated disaccharides, trisaccharides, and tetrasaccharides were eluted at 34.2, 32.4, and 30.8 min, respectively. The mixture of unsaturated disaccharides, trisaccharides, and tetrasaccharides was used as the marker, and the total uronic acid concentration was 0.2% (w/v).
Primers used in this study.
| Primers | Sequence (5′ to 3′) | Usage |
|---|---|---|
| Expression of TsAly7B and truncated proteins | ||
| TsAly7B-FL-F | CATG | Expression of TsAly7B-FL |
| TsAly7B-FL-R | CCG | |
| TsAly7B-TM1-F | CATG | Expression of TsAly7B-TM1 |
| TsAly7B-TM1-R | CCG | |
| TsAly7B-TM2-1-F | CATG | Expression of TsAly7B-TM2 |
| TsAly7B-TM2-1-R | CG | |
| TsAly7B-TM2-2-F | CG | |
| TsAly7B-TM2-2-R | CCG | |
| TsAly7B-TM3-F | CATG | Expression of TsAly7B-TM3 |
| TsAly7B-TM3-R | CCG | |